> top > docs > PMC:7152526 > spans > 16365-16949 > annotations

PMC:7152526 / 16365-16949 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
376 73-81 Species denotes patients Tax:9606
377 164-172 Species denotes patients Tax:9606
378 575-583 Species denotes patients Tax:9606
379 106-114 Disease denotes COVID-19 MESH:C000657245
380 115-124 Disease denotes infection MESH:D007239
381 566-574 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T113 61-67 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T114 425-431 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T115 544-550 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T103 106-114 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T104 115-124 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T105 566-574 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T164 61-67 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T165 425-431 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T166 544-550 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T75 247-262 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T76 343-358 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T20 318-339 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T118 0-216 Sentence denotes Despite the limitations, our cases suggest that convalescent plasma from patients who have recovered from COVID-19 infection might be an additional option to treat patients without causing any severe adverse effects.
T119 217-447 Sentence denotes Also, when used with systemic corticosteroids, we might expect the possibility of reducing excessive inflammatory response by corticosteroids as well as promoting the reduction of viral loads by convalescent plasma simultaneously.
T120 448-584 Sentence denotes Further well-designed studies are needed to demonstrate the efficacy and safety of convalescent plasma transfusion in COVID-19 patients.

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T264 61-67 UBERON:0001969 denotes plasma
T265 106-114 SP_7 denotes COVID-19
T266 247-262 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T267 343-358 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T268 397-402 NCBITaxon:10239 denotes viral
T269 425-431 UBERON:0001969 denotes plasma
T270 544-550 UBERON:0001969 denotes plasma
T271 566-574 SP_7 denotes COVID-19
T31952 61-67 UBERON:0001969 denotes plasma
T56557 106-114 SP_7 denotes COVID-19
T11836 247-262 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T92146 343-358 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T78664 397-402 NCBITaxon:10239 denotes viral
T21512 425-431 UBERON:0001969 denotes plasma
T78481 544-550 UBERON:0001969 denotes plasma
T93841 566-574 SP_7 denotes COVID-19